Post

MSD competes with Pfizer in pneumococcal vaccine market after FDA approval  

Merck & Co (MSD) has won US Food and Drug Administration (FDA) approval for its 21-valent pneumococcal vaccine, Capvaxive, for …

Ability Biologics closes extended $18m seed funding round

Cancer-focused biotech Ability Biologics has announced the close of an $18m seed funding extension round. The Canadian biotech uses its generative …

Pharmaceutical cleaning equipment, agents and services

Pharmaceutical cleaning equipment, agents and services: Introduction  In the highly regulated pharmaceutical sector, the importance of maintaining impeccable cleanliness cannot be …

Sanofi and Belharra forge $700m partnership for immunological diseases

Belharra Therapeutics has announced that it has entered a strategic partnership with global powerhouse Sanofi to spur the development of …

Pyros wins FDA approval for ready-to-use infantile spasm treatment

The US Food and Drug Administration (FDA) has signed off on a ready-to-use formulation of vigabatrin developed by Pryos Pharmaceuticals …